Oral Bisphosphonates and Risk of Subtrochanteric or Diaphyseal Femur Fractures in a Population-Based Cohort

Bisphosphonates are the primary therapy for postmenopausal and glucocorticoid-induced osteoporosis. Case series suggest a potential link between prolonged use of bisphosphonates and low-energy fracture of subtrochanteric or diaphyseal femur as a consequence of oversuppression of bone resorption. Usi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seo Young, Schneeweiss, Sebastian, Katz, Jeffrey N, Levin, Raisa, Solomon, Daniel H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Subscription Services, Inc., A Wiley Company 2011
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179299/
https://www.ncbi.nlm.nih.gov/pubmed/21542002
http://dx.doi.org/10.1002/jbmr.288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179299/
https://www.ncbi.nlm.nih.gov/pubmed/21542002
http://dx.doi.org/10.1002/jbmr.288

Ejemplares similares